December 17, 2024 03:02 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
GRAP 4 restrictions reimposed in Delhi as air quality dips to 'severe' category | 39 ministers included in Devendra Fadnavis-led Maharashtra cabinet | People who raise questions on EVMs should show how they can be hacked: TMC trashes Congress claims | Bangladesh likely to hold national polls in late 2025 or early 2026, says Yunus in Victory Day speech | Constitution stood test of time: Nirmala Sitharaman in Rajya Sabha | PM Museum requests Rahul Gandhi to return Pandit Nehru's historical letters | Indian tabla maestro Zakir Hussain dies at 73 in San Francisco, confirms family | Kolkata woman strangled, beheaded and chopped into pieces for refusing brother-in-law's advances | Arvind Kejriwal, CM Atishi to contest Delhi polls from current constituencies | Atul Subhash suicide case: Wife Nikita, her mother and brother arrested
Strides Pharma Q4FY23 sales at Rs 9,904 million cr, up 14%Y-o-Y; loss narrows 133% YoY to Rs 9.54 cr

Strides Pharma Q4FY23 sales at Rs 9,904 million cr, up 14%Y-o-Y; loss narrows 133% YoY to Rs 9.54 cr

May 31, 2023, at 06:23 pm

Mumbai: Strides Pharma’s quarterly sales stood at Rs 9,904 million, growing 14% increase both sequentially and year-on-year.

Strides Pharma records 11 pc YoY revenue increase in Q2FY21

Strides Pharma records 11 pc YoY revenue increase in Q2FY21

Oct 30, 2020, at 04:52 am

Kolkata/IBNS: Strides Pharma Science Ltd (BSE: 532531, NSE: STAR) today announced its consolidated financial results for the quarter (Q2FY21).